NHF Statement on Shire Injunction Filing on Roche/Genentech
NHF is aware that recently Shire sought an injunction against Roche/Genentech. The reasons for the injunction and the relief being sought were sealed. NHF has no other knowledge of the preliminary details.
NHF will NOT engage in the dialogue around patent ownership and will not be ‘choosing a side’ relative to this suit. NHF will remain focused on patient access to care and if and when we feel that is being jeopardized, we will take any and all action necessary to ensure patient access to their prescribed therapies is not interrupted or denied. We are hopeful that both sides will conduct themselves in a way that will not jeopardize the health of the patients in the bleeding disorders community.
To read the statement issued by Shire, click here. If a statement becomes available from Roche/Genentech we will make that available.